Myriad RBM’s ExplorerMAP testing service provides quantitative measurement of Myriad RBM’s most frequently requested biomarkers. Developed as an economical alternative to our DiscoveryMAP testing service, ExplorerMAP is ideal for researchers seeking a comprehensive understanding of the biology underlying the disease, condition or compound being studied. Spanning nearly 150 select biomarkers including important cytokines, acute phase reactants, growth factors and cancer markers, ExplorerMAP can be utilized by drug and diagnostic developers in several therapy areas including inflammation, immune response, cardiovascular, neurological, metabolic and cancer.
1 This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only.
2 This assay did not meet performance specifications in Serum and results should be used for information purposes only.
Intended for Research Use Only.
|Serum or plasma||Other fluids*|
|220 µL||800 µL|